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Human dermal fibroblasts grown in tissue culture can 
be suspended and cultured in collagen lattices. These 
fibroblast-populated collagen lattices (FPCL) undergo a 
reduction in size by the process of lattice contraction. 
Fibroblasts from patients with epidermolysis bullosa 
dystrophica recessive, EBdr, produce excessive quan-
tities of cAMP. These high concentrations of cAMP may 
be related to the inability of the EBdr fibroblast to 
elongate and spread out when incorporated into the 
collagen matrix. Fibroblasts with these morphologic 
characteristics are not effective in contracting collagen 
lattices. EBdr fibroblasts in FPCL have intracellular 
concentrations of cAMP 8 times greater than those of 
normal fibroblasts in FPCL. They also have a dendritic 
morphology. The addition of cholera toxin or dibutyryl 
cAMP to normal human fibroblasts will cause elevated 
levels of intracellular cAMP and will inhibit the elon-
gation and spreading of cells and lattice contraction. 
The cytoskeletal morphology of EBdr fibroblasts differs 
from that of normal human fibroblasts in FPCL. The use 
of rhodamine phalloidin, a specific fluorescent stain for 
F-actin filaments, reveals that EBdr fibroblasts show a 
pattern of actin distribution shared by normal fibro-
blasts cultured in the presence of dibutyryl cAMP or 
cholera toxin. It is proposed that the contractile forces 
responsible for lattice contraction are identical to those 
forces responsible for the spreading and elongation of 
cells. EBdr fibroblasts fail to spread and elongate within 
a collagen matrix and are therefore not effective in 
lattice contraction. 
Epidermolysis bullosa dystrophica recessive, EBdr, is an 
inherited disease clinica lly characterized by induction of blis-
te rs in skin and mucosal surfaces by minor trauma [1]. The 
an atomic location of the blister formation in skin is between 
the basement membrane plane and t he papillary dermal layer. 
The structure of collagen fibers within the papillary dermis of 
t he affected area shows breakdown and localized destruction 
[2]. Tissue-cultured fibrobla sts derived from patients with 
EBdr show an increased synthesis and secretion of mammalian 
collage nase [3,4]. The EBdr collagenase appears to be structur-
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Abbreviations: 
cAMP: cyclic AMP 
db cAMP: dibutyryl cyclic AMP 
DMEM: Dulbecco's modification of Eagle's medium 
EBdr: epidermolysis bullosa dystrophica recessive 
FBS: fetal bovine serum 
FPCL: fibroblast -populated collagen lattice(s) 
PBS: physiologic buffered saline 
PG: prostaglandin 
Rb-phalloidin: rhodamine phalloidin 
TCA: t richloroacetic ac id 
ally altered, having a lower thermal stability and a lower affinity 
for its metal cofactor calcium [5-7]. 
EBdr fibroblasts entrapped in a collagen matrix have a 
dendritic appearance as demonstrated with phase contrast op-
tics and scanning electron microscopy [8) . In contrast, normal 
human fibroblasts within a collagen matrix have an elongated 
and bipolar spread-out appearance [8,9]. Fibroblasts incorpo-
rated into a collagen matrix reduce the size of that matrix by 
the process referred to as lattice contraction [9] . EBdr fibro-
blasts incorporated into a collagen lattice show an inability to 
spread out and they are less effective in contracting a collagen 
lattice. 
Fibroblast-like cells isolated from the synovium of rheumatic 
arthritic joints have a dendritic morphology [10] . These den-
dritic cells produce increased amounts of collagenase and pros-
taglandin E2 (PGE2) [11 ,12]. Elevated levels of PGE2 will 
promote enhanced synthesis of int racellular cAMP [13]. Since 
EBdr fibroblasts reportedly produce excess amounts of colla-
genase and PGE~. the possibility exists that these cells a lso 
produce increased amounts of intracellular cAMP. Increased 
intracellular concentrations of PGs a lter cell morphology 
within the collagen lattice and inhibit lattice contraction 
[14,15) . In this study the EBdr fibroblasts within fibroblast-
populated collagen lattices (FPCL) were assayed for cAMP. 
The effect of indomethacin, a nonsteroid anti-inflammatory 
drug, on the inhibition of the synthesis of PGs and intracellular 
cAMP was measured. In EBdr cells, the reduction by indo-
methacin of intracellular cAMP levels produced a normal mor-
phologic appearance within the FPCL and promoted normal 
lattice contraction. 
MATERIALS AND METHODS 
The pepsin-solubilized collagen used in these studies was extracted 
from a benign uterine neoplasm, leiomyoma. After surgical removal 
and pathologic examination, leiomyomas were frozen and powdered in 
a Spex Freezing Mill, (Metuchen, New Jersey). This fresh powdered 
tissue was taken up in 0.5 M acetic acid with 0.1% pepsin w/ v, stirred 
at 2· c for 48 h, then centrifuged at 10,000 g for 10 min, and the 
collagen-rich supernatant was saved. The supernatant was neutralized 
with 2 M sodium hydroxide, and sodium chloride was added to a final 
concentration of 20% w/v. The mixture was stirred overnight at 2·c, 
then centrifuged at 10,000 g for 15 min and the pellet saved. The pellet 
was suspended in 0.1 M acetic acid and dialyzed against 1 mM hydro-
chloric ac id. The collagen solution was cleared by centrifugation at 
10,000 g for 30 min, and the supernatant was frozen, lyophilized, 
weighed, and taken up in steri le 1 mM hydrochloric acid at a concen-
tration of 5 mg/ml. The collagen solution was kept at 2· c unt il needed. 
Dulbecco's modification of Eagle's medium (DMEM) containing a 
final concentrate of 20% v/v fetal bovine serum (FBS) and 25 J.Lg/ml 
gentamicin was used in all the noted experiments. Fibroblasts for these 
experiments were described previously [8,15]; the EBdr cell lines used 
were gifts from Dr. H. P. Baden, Dermatology Service, Massachusetts 
General Hospital. Dr. A. Mulinski, Boston University Medical Center, 
supplied cell line 3358 which is the parent of EBdr fibroblast line 3592. 
Dr. R. W. Erbe, Pediatrics Department, Massachusetts General Hos-
pital, supplied the normal fibroblast line MGH 287 which is age-
matched to the EBdr cell line studied. 
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FPCL were manufactured by rapidly mixing together in a 35-mm 
bacteriologic Petri dish 1 ml of culture medium, 0.5 ml of the fibroblasts 
suspended in the same medium, and 0.5 ml of cold collagen solution in 
1 mM hydrochloric acid. The collagen polymerized in less than 2 min 
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at 3 7 • c in 5% C0 2 and 95% moist air atmosphere, entrapping fibro· 
b lasts wi thin its polymerized matri x. 
Age nts were added to the medium prior to the mixing of cells, 
mediu m, and collagen. Indomethacin, (Sigma, St. Louis, Missouri) , was 
added at the concentration of 10 pg/ ml. Cycl ic nucleotide preparations, 
cAMP and dibutyryl (db) cAMP (Sigma) were used at 10-3 and 10-6 M 
fi n a l concentrations. Cholera toxin (Sigma) was used at 1 x 10-6 and 
5 x 1 0 -6 M. T he area of the FPCL was recorded directly by measuring 
t he dia meter to the nearest 0.5 mm. 
A p ort ion of the lattice was cut and t ransferred to a glass coverslip 
for morphologic examination. The specimens were then covered with 
glass microscope slides and examined. Fibroblast morphology was 
docu mented with a Zeiss IM 35 inverted microscope equipped wi th 
Nomar ski optics and epifluorescence. Panatomic X 35-mm film was 
used to photograph cells wi thin lattices. For flu orescent studies Kodak 
Ektachrome 400 ASA 35-mm film was used and uprated to 1600 ASA 
during processing. 
Staining for F-actin fil amentous stress fibers was accomplished with 
rhoda mine phalloidin (Rb-phalloidin) (Molecular Probes, Inc., Oregon) 
(16] . P halloidin is a mushroom toxin which binds specifically to F-
actin [17]. FPCL on glass coverslips were fi xed for 5 min in 4% 
paraformaldehyde, washed 3 times in physiologic buffered saline (PBS) 
and t h en permeabilized with 0. 1% Tri ton X-100 in PBS for 5 min. The 
specimen was washed again 3 times with PBS and incubated for 30 
m in in Rb-phalloidin at 1:100 dilut ion in PBS. Coverslips were washed 
3 t imes in PBS, mounted in 9: 1 glycerol:PBS and examined with 
epi flu orescence using the appropriate rhodamine fil te rs. 
Con cent rations of cAMP were measured in 48-h-old lattices. The 
medium was removed at 48 h and the populated lattice was extracted 
in 5% t richloroacetic ac id (TCA) using the instructions furnished with 
the cAM P radioimmunoassay kits purchased from Boehringer Mann · 
heim (Indianapolis, Indiana). The calculated concent rations of cAMP 
from t h e radioimmunoassay results utilized a published log-logit pro-
cedure applicable to a hand-held calculator [1 8]. Data was statistically 
averaged using a nonpaired Student's t-test. 
RESULTS 
Lattice Contraction and cAMP Concentration 
A fte r 48 h in cul ture, FPCL ini t ia lly con taining 70,000 cells 
wer e assayed for cAMP. Normal M GH -287 fibroblast lattices 
h a d 0 .46 pmol cAM P per 104 cells. Levels of cAMP in EBdr-
3592 fibroblast lattices were elevated to 7.28 pmol per W' cells . 
At 48 h t he norma l FPCL had reduced its a rea from 800 mm2 
to 132 mm2 , while the EBdr-3592 FPCL cont racted to 314 mm2 
(Table I, experiment 1) . 
The direct addit ion of cAMP to normal FPCL at 10- 4 M to 
10- 3 M did not a lter lattice con t raction at 48 h (Fig 1). This 
was to be expected since fibroblasts cannot take up cAMP. 
Unlike cAMP, db cAMP is taken up by fibroblasts and in -
crea ses intrace llula r level s of cAMP. Lat tice con t rac tion was 
inhibited at 48 h by t he addi t ion of db cAMP at w-r, M to w-:1 
M (Fig 1). The inhibitory activity of db cAMP is dose-dependent 
fro m 10- 6 M to w-a M . A cont rol experiment wi th the addi t ion 
of butanol to FPCL at 0.1% v /v did not alter lattice contraction 
at 48 h. 
C h o lera toxin stimulates adenylate cyclase activity and in -
creases cAMP synt hesis and accumulat ion . Treated normal 
MGH -287 fibroblasts in FPCL had cAMP levels of 6.06 pmol 
per 10,000 cells compared to 0.46 pmol per 10,000 cells in 
u n t reated cont rols a t 48 h (Table I, experiment 2) . The addition 
of c h o lera toxin to medium durin g the manufacture of normal 
FP C L inhibited lattice contract ion (Table I, experiment 2). 
Hen ce, the stimulation of adenylate cyclase by cholera toxin 
promot ed t he synthesis and int racellular accumulation of 
cAMP, result ing in retarded FPCL cont raction. 
PGE 2 can stimulate adenylate cyclase activi ty, thereby caus-
ing t h e int racellular accumulation of cAMP. When normal 
human fibroblasts were incorporated into FPCL in t he presence 
of P GE2, lattice cont ract ion was inhibited and cAMP levels 
were 6.80 pmol pe r 10,000 compared to 0.46 pmol per 10,000 in 
untreated cont rols (T able I, experiment 3 ). EBdr fibroblasts 
produce elevated levels of PGE2 [15]. EBdr FPCL made in t he 
presen c e of indomethacin , a cyclooxygenase inhibi tor , showed 
T ABLE I. FPCL contraction and cAMP concentration comparisons 
between EBdr and normal fibroblasts 
1. MGH -287 
EBdr-3592 
2. MGH-287 
Experi ment 
+ db cAMP 10-5 M 
+ cholera toxin lO-G M 
3. MGH-287 
MGH-287 + PGE2 10 pg/ml 
EBdr-3592 
EBdr-3592 + indomethacin 10 pg/ ml 
pmol 
cAMP/ 10' 
cells 
0.46 
7.28 
0.46 
6.06 
0.46 
6.80 
7.28 
0.76 
FPCL 
area 
132 mm 2 
314 mm2 
132 mm2 
227 mm 2 
283 mm2 
132 mm2 
298 mm2 
314 mm2 
132 mm2 
FPCL were made with 7 x 10' fibroblasts per 2 ml of lattice. The 
lattices were measured at 48 h and cAMP levels were assayed at that 
ti me. 
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FIG 1. Dose-dependent response of added cyclic nucleotides on lat-
tice contraction. FPCL were manufactured with 70,000 normal human 
fibroblasts, 20% v/ v FBS, 2.5 mg soluble collagen, and DMEM with 
addit ions to a final volume of 2.0 ml in 35-mm Petri dishes. Lattice 
area was recorded at 48 h: The addi tion of cAMP (identified by open 
boxes) d1d not affect latt1ce contractiOn. The addit ion of db cAMP 
(iden t ified by solid triangles ), which is taken up by cells, inhibited 
latt1ce contraction m a dose-dependent response. 
levels of cAMP reduced to 0.76 pmol per 10,000 cells (T able I, 
experiment 3) and lattice con t raction iden tical to that in t he 
normal FPCL. 
Fibroblast Morphology 
EBdr fibroblasts en t rapped in a collagen lattice do not spread 
out or elongate as well as normal fibroblasts [8 ]. Di ffe rences 
between t he a ffected and normal fibroblasts were readily dem -
onstrated at 24 h by N omarski opt ics (Fig 2A,B) . The addi t ion 
of db cAMP at 2 X 10- 3 M to normal MGH-287 FPCL a ltered 
fibroblast morphology at 24 h (Fig 2C ) and inhibited lattice 
cont raction . The db cAMP inhibited t he ability of fibroblasts 
to spread out and elongate. S imila rly, t he addition of cholera 
toxin to normal fibroblasts altered their morphology (Fig 2D ) 
and inhibi ted cont raction . PGE2, like cholera toxin , promoted 
the syn thesis of int racellular cAMP (T able I) . The addition of 
indomethacin to EBdr FPCL inhibited t he synt hesis of PGE2 
and cAMP, and promoted t he spreading of cells (Fig 2E) . It is 
clear t hat t he elevation of int racellular cAMP levels by db 
cAMP, cholera toxin , or PGE2 affects t he morphology of normal 
human fibroblasts in FPCL. Treated normal human fibroblasts 
look like E Bdr fibroblasts. 
232 EHRL ICH AND GRISWOLD 
FIG 3. Fluorescent stained actin fil aments in normal or EBdr FPCL. 
Pie-shaped wedges were cut from 48-h-old FPCL made with normal or 
EBdr human fibroblasts and were transferred to glass coverslips. Tissue 
on the coversli ps was fixed, permeabilized, and incubated with Rb-
phalloidin , and then mounted and examined wi th epif1uorescence. Bars 
= 10 /.lm . A, FPCL made wi th 50,000 normal human fibrobl asts show 
elongated fibroblasts with actin filaments in the long arms of the cells. 
These cells are located at the periphery of the lattice. B, FPCL made 
with 70,000 fibroblasts, 3592 cells, show fibrobl asts with dendritic arms 
having stained actin filaments in these numerous fil opodia. These cells 
are located at the periphery of the lattice. C, FPCL with 50,000 normal 
human librobla ·ts and 10-4 M db cAMP show actin fi laments within 
t.he numerous dendritic arms of this cell. D, FPCL made with 10-6 M 
cholera tox in and normal human fibroblasts show a dendritic cell shape 
with stained filaments within the dendri t ic arms. E, FPCL made with 
5 l.lg/ml of PGE~ and normal human fibroblasts show numerous fil a-
ments within the dendri tic arms of the cells. F, FPCL made with 
indomethacin , 10 l.lg/ml, and EBdr fibroblasts show a spindle-shaped 
cell with diffuse microfil aments within the bipolar arms of the cell. 
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FIG 2. Normal human fibroblast and 
EBdr fibroblast morphology within 
FPCL. FPCL were examined with No-
marski optics at 48 h in unfixed speci-
mens by the transfe r of pie-shaped 
wedges from the lattices to glass cover-
slips. FPCL were made with 50,000-
70,000 fibroblasts, FBS, soluble collagen, 
and DMEM. Agents were included in the 
ini tial manufacture of lattices. Bars = 10 
/.lm . A, Normal human fibroblasts show 
this typical elongated shape in FPCL. B, 
EBdr 3592 fibroblasts show this den-
dritic morphology. They are less effec-
tive at elongating and spreading out 
within the collagen matrix. C, Normal 
human fibroblasts in the presence of 10-• 
M db cAMP have a dendrit ic morphology 
similar to EBdr cells. D, Normal human 
fibroblasts in FPCL made with 5 X 10-6 
M cholera toxin show dendri tic cellular 
morphology. E, The addition of indo-
methacin at 10 /.lg/ml to EBdr FPCL 
reduced cA MP concent ration and pro-
duced a cell morphology like that of nor-
mal human fibroblasts. 
Fibroblast cytoskeleta l structures within FPCL were exam-
ined by Rb-phalloidin staining of lattices 24 h after manufac-
ture. Normal human FPCL show very fine F-actin microfila -
ments in the cytoplasm (Fig 3A ). In cont rast, EBdr FPCL show 
actin fil ame nts in t he dendritic arms (Fig 3B ). Their morpho-
logic appearance is unlike that of normal human fibroblasts. 
Adding db cAMP to norma l FPCL produces an F -actin filament 
pattern like that of EBdr FPCL (Fig 3C). S imila rly, treating 
normal fibroblasts with cholera toxin or PGE2 elevates t he 
intracellular concentrations of cAMP and reveals an F -actin 
filament pattern similar to EBdr FPCL (Fig 3D,E). Making 
EBdr FPCL in t he presence of indomethacin promoted F-actin 
fil ament patterns simila r to those of normal FPCL (Fig 3F). 
DISCUSSION 
Cultured fibrobl asts derived from individua ls affected with 
EBdr a re morphologically and functiona lly different from nor-
mal human fibroblasts. FPCL made with affected fibroblasts 
show a lack of fibroblast elongation and spreading which ap-
pears responsible for retarded lattice contraction [8). The al-
teration of fibroblast morphology and the resultant inability to 
cont ract collagen lattices effectively has been documented in 
FPCL made with transformed fibroblasts [19], and in normal 
FPCL treated with interleukin 1 or PGE, [14,15]. The addit ion 
of soluble factor( s) synt hesized by activated monocytes alters 
the morphology of fibroblasts, resulting in retarded lattice 
contraction [1 4). It appears t hat the mechanism for shape 
change resulting in retarded lattice contraction is t he promo-
tion of PGE synt hesis which stimulates adenylate cyclase ac-
tivity and elevates concentrations of intracellular cAMP. EBdr 
fibroblasts residing in an FPCL synt hesize more PGE2 t han do 
normal fibroblasts residing within an FPCL [15). There is a 
13-fold increase in PGE, concent ration as measured in medium 
from 48- h EBdr FPCL compared to normal FPCL. The addi-
t ion of indomethacin to EBdr FPCL reduces the amount of 
PGE synthetized [15). The addi t ion of indomethacin to normal 
FPCL neit her a lters t he morphology nor promotes enhanced 
contraction in t hat FPCL. However, t he addit ion of indometh-
acin to EBdr FPCL promotes lattice contraction, cell elonga-
tion and spreading, and a cytoskeletal morphology identical to 
that of normal human fibroblasts. In addition to inhibiting t he 
synthesis of PGE2, indomethacin a lso reduces t he levels of 
intracellular cAMP. 
PGE~ stimulates adenylate cyclase activity, thereby increas-
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ing cAMP production [20]. Cholera toxin also stimulates cAMP 
synthesis within fibroblasts (21 ]. Adding cholera toxin to FPCL 
made with normal fibroblasts causes re tarded lattice contrac-
tion. The direct addition of db cAMP which can be taken up 
by fibroblasts inhibits FPCL contraction and prevents cell 
elongation. These treated fibroblasts that are prevented from 
spreading and elongating demonstrate retarded lattice contrac-
tion. 
Rhodamine phalloidin-stained monolayer fibroblasts show 
parallel stress fibers 24 h after plating. Very fine parallel F -
actin filaments are found at 24 h in normal fibroblasts incor-
porated into collage n lattices. In contrast, the F-actin filaments 
in EBdr fibroblasts stain more intensely within the dendritic 
a rms of the cells. This F -actin distribution is simi lar to normal 
human fibroblasts with elevated levels of cAMP. 
Elevated levels of collagenase production reported in mono-
layer cultured EBdr cells suggest that PGE synthesis may also 
be elevated [3, 10] . Some cells in primary synovial cell cultures 
a re spindle shaped. After t he addition of exogenous PGE2 to 
these cultured cells, morphologic changes occur resulting in 
convers ion of their spindle shape to a dendritic form . When 
PGE is removed from these cells they return to their spindle 
shape within 1 h [13]. The direct addition of cholera toxin or 
db cAMP to the cultured fibroblasts produces a dendritic ap-
pearance [22]. Increased intracellular levels of cAMP change 
the organization of the ce llular microtubules and microfila-
ments. This consequently alters the cell morphology [23). 
Evidence presented indicates that the increased production 
of PG E 2 by EBdr fibroblasts leads to elevated intracellular 
concentrations of cAMP. One effect of these biochemical 
changes is a retarded spreading and elongation of cells when 
incorporated i11to a collagen matrix. Microfilaments are essen-
tial to the spreading of ce lls. EBdr fibroblast F -actin filaments 
are present but they are arranged differently than in normal 
human fibroblasts . 
Stopak and Harris proposed that the fibroblast contractile 
process works by direct physical pulling rather than by a simple 
contraction of individual cells [24]. Fibroblasts do not shorten 
in length as contracting striated muscle does. They proposed 
that a "traction force" is responsible for lattice contraction. 
This is a shearing force, tangential to the cell surface, associated 
with spreading and elongation of the cell [25]. Fibroblasts may 
contract a collagen lattice with traction forces identical to those 
fo rces that promote cell elongation and spreading. The inhibi -
tion of these traction forces would result in the absence of the 
spreading and elongation of fibroblasts which would prevent 
lattice contraction. Traction forces generated by fibroblasts can 
distort the elastic surfaces beneath the cell [2.5 ). Observations 
made with FPCL appear to support the Stopak-Harris traction 
force hypothesis. Lattice contraction occurs by the action of 
independent cellular forces which appear to be generated by 
the elongation and spreading of cells. Fibroblasts viewed by 
phase contrast optics remain elongated throughout the process 
of lattice contraction. 
The inhibition of PGE and cAMP synthesis by the addition 
of t he nonsteroid anti- inflammatory drug indomethacin to 
EBdr FPCL may have some clinical value. It is shown that 
synovial fibroblasts in tissue culture can be stimulated to 
produce excess amounts of collagenase, PGE, and cAMP [10] . 
Indomethacin blocks PGE synthesis and cAMP accumulation, 
but it does not alter t he elevated synthesis and secretion of 
collagenase [12]. Should excess collagenase be the major cause 
of blistering associated with EBdr syndrome, then the inhibi -
tion of PGE synthesis may not be beneficial to the patient. 
However , if this syndrome is associated with elevated levels of 
both PGE2 and intracellular cAMP, then nonsteroid anti-
inflamma tory drug therapy may be advised. 
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